LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci

FEMS Microbiology Letters

Volumn 287, Issue 1, 2008, Pages 22-33

  Donovan, David M ^a,b   Foster Frey, Juli ^a  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Amidase; B30 endolysin; Bacteriophage endolysin; Peptidoglycan hydrolase; Synergy

Indexed keywords

AMIDASE; AMIDASE 5; BACTERIAL PROTEIN; CPL 7 PROTEIN; ENDOLYSIN; GLYCOSIDASE; HYDROLASE; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BACTERIAL STRAIN; COAGULASE NEGATIVE STAPHYLOCOCCUS; LAMBDASA2 PROPHAGE; LYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PROPHAGE; PROTEIN BINDING; PROTEIN DOMAIN; STAPHYLOCOCCUS XYLOSUS; STREPTOCOCCUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUI; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS UBERIS; TURBIDITY;

AMIDOHYDROLASES; ANTI-BACTERIAL AGENTS; BACTERIOLYSIS; CELL WALL; ENDOPEPTIDASES; MICROBIAL SENSITIVITY TESTS; PROPHAGES; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION; STREPTOCOCCUS; STREPTOCOCCUS PHAGES;

ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS XYLOSUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUI; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS UBERIS;

EID: 50949103946     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2008.01287.x     Document Type: Article

References (47)

1. Anonymous (2007) Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae - Massachusetts, 2001-2006. Morb Mortal Wkly Rep 56 : 1077 1080.
2. Baba T Schneewind O (1996) Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus. EMBO J 15 : 4789 4797.
3. Bera A, Biswas R, Herbert S Gotz F (2006) The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun 74 : 4598 4604.
4. Cheng Q Fischetti VA (2007) Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci. Appl Microbiol Biotechnol 74 : 1284 1291.
5. Cheng Q, Nelson D, Zhu S Fischetti VA (2005) Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother 49 : 111 117.
6. Davies D (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2 : 114 122.
7. Davies MR, McMillan DJ, Beiko RG, Barroso V, Geffers R, Sriprakash KS Chhatwal GS (2007) Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases. Clin Infect Dis 44 : 1442 1454.
8. Donovan DM, Dong S, Garrett W, Rousseau GM, Moineau S Pritchard DG (2006a) Peptidoglycan hydrolase fusions maintain their parental specificities. Appl Environ Microbiol 72 : 2988 2996.
9. Donovan DM, Foster-Frey J, Dong S, Rousseau GM, Moineau S Pritchard DG (2006b) The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/ peptidase domain. Appl Environ Microbiol 72 : 5108 5112.
10. Entenza JM, Loeffler JM, Grandgirard D, Fischetti VA Moreillon P (2005) Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother 49 : 4789 4792.
11. Fischetti VA (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 13 : 491 496.
12. Garcia P, Garcia JL, Garcia E, Sanchez-Puelles JM Lopez R (1990) Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Gene 86 : 81 88.
13. Gottschalk M, Segura M Xu J (2007) Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim Health Res Rev 8 : 29 45.
14. Grundling A Schneewind O (2006) Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol 188 : 2463 2472.
15. Hermoso JA, Garcia JL Garcia P (2007) Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr Opin Microbiol 10 : 461 472.
16. Kim MK, Jee H, Shin SW, Lee BC, Pakhrin B, Yoo HS, Yoon JH Kim DY (2007) Outbreak and control of haemorrhagic pneumonia due to Streptococcus equi subspecies zooepidemicus in dogs. Vet Rec 161 : 528 530.
17. Koehl JL, Muthaiyan A, Jayaswal RK, Ehlert K, Labischinski H Wilkinson BJ (2004) Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 48 : 3749 3757.
18. Kusuma CM Kokai-Kun JF (2005) Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus. Antimicrob Agents Chemother 49 : 3256 3263.
19. Lloyd DH (2007) Reservoirs of antimicrobial resistance in pet animals. Clin Infect Dis 45 : (suppl 2) : S148 S152.
20. Loessner MJ (2005) Bacteriophage endolysins - current state of research and applications. Curr Opin Microbiol 8 : 480 487.
21. Loessner MJ, Gaeng S, Wendlinger G, Maier SK Scherer S (1998) The two-component lysis system of Staphylococcus aureus bacteriophage Twort: a large TTG-start holin and an associated amidase endolysin. FEMS Microbiol Lett 162 : 265 274.
22. Lopez R Garcia E (2004) Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol Rev 28 : 553 580.
23. Low LY, Yang C, Perego M, Osterman A Liddington RC (2005) Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem 280 : 35433 35439.
24. Lu JZ, Fujiwara T, Komatsuzawa H, Sugai M Sakon J (2006) Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges. J Biol Chem 281 : 549 558.
25. Mathew AG, Cissell R Liamthong S (2007) Antibiotic resistance in bacteria associated with food animals: a United States perspective of livestock production. Foodborne Pathog Dis 4 : 115 133.
26. McDonald HM, Pruett PS, Deivanayagam C, Protasevich II, Carson WM, Delucas LJ, Brouillette WJ Brouillette CG (2007) Structural adaptation of an interacting non-native C-terminal helical extension revealed in the crystal structure of NAD+ synthetase from Bacillus anthracis. Acta Crystallogr D Biol Crystallogr 63 : 891 905.
27. Niederman MS (2007) Recent advances in community-acquired pneumonia: inpatient and outpatient. Chest 131 : 1205 1215.
28. Passali D, Lauriello M, Passali GC, Passali FM Bellussi L (2007) Group A Streptococcus and its antibiotic resistance. Acta Otorhinolaryngol Ital 27 : 27 32.
29. Perez-Dorado I, Campillo NE, Monterroso B et al 2007) Elucidation of the molecular recognition of bacterial cell wall by modular pneumococcal phage endolysin CPL-1. J Biol Chem 282 : 24990 24999.
30. Perron-Savard P, De CG Le MH (2005) Dimerization and DNA binding of the Salmonella enterica PhoP response regulator are phosphorylation independent. Microbiology 151 : 3979 3987.
31. Porter CJ, Schuch R, Pelzek AJ et al 2007) The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis. J Mol Biol 366 : 540 550.
32. Pritchard DG, Dong S, Baker JR Engler JA (2004) The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology 150 : 2079 2087.
33. Pritchard DG, Dong S, Kirk MC, Cartee RT Baker JR (2007) LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae. Appl Environ Microbiol 73 : 7150 7154.
34. Rashel M, Uchiyama J, Ujihara T et al 2007) Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis 196 : 1237 1247.
35. Resch A, Rosenstein R, Nerz C Gotz F (2005) Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol 71 : 2663 2676.
36. Salata RA, Lerner PI, Shlaes DM, Gopalakrishna KV Wolinsky E (1989) Infections due to Lancefield group C streptococci. Medicine (Baltimore) 68 : 225 239.
37. Sanchez-Puelles JM, Sanz JM, Garcia JL Garcia E (1990) Cloning and expression of gene fragments encoding the choline-binding domain of pneumococcal murein hydrolases. Gene 89 : 69 75.
38. Schleifer KH Kandler O (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36 : 407 477.
39. Sylvetsky N, Raveh D, Schlesinger Y, Rudensky B Yinnon AM (2002) Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med 112 : 622 626.
40. Tettelin H, Masignani V, Cieslewicz MJ et al 2002) Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci USA 99 : 12391 12396.
41. Wall RJ, Powell AM, Paape MJ, Kerr DE, Bannerman DD, Pursel VG, Wells KD, Talbot N Hawk HW (2005) Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol 23 : 445 451.
42. Wessman GE (1986) Biology of the group E streptococci: a review. Vet Microbiol 12 : 297 328.
43. Wilson DJ, Gonzalez RN Das HH (1997) Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production. J Dairy Sci 80 : 2592 2598.
44. Woestenenk EA, Hammarstrom M, van den BS, Hard T Berglund H (2004) His tag effect on solubility of human proteins produced in Escherichia coli: a comparison between four expression vectors. J Struct Funct Genomics 5 : 217 229.
45. Yang XY, Li CR, Lou RH, Wang YM, Zhang WX, Chen HZ, Huang QS, Han YX, Jiang JD You XF (2007) In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China. J Med Microbiol 56 : 71 76.
46. Yokogawa K, Kawata S, Nishimura S, Ikeda Y Yoshimura Y (1974) Mutanolysin, bacteriolytic agent for cariogenic streptococci: partial purification and properties. Antimicrob Agents Chemother 6 : 156 165.
47. Yokoi KJ, Kawahigashi N, Uchida M, Sugahara K, Shinohara M, Kawasaki K, Nakamura S, Taketo A Kodaira K (2005) The two-component cell lysis genes holWMY and lysWMY of the Staphylococcus warneri M phage varphiWMY: cloning, sequencing, expression, and mutational analysis in Escherichia coli. Gene 351 : 97 108.